Speaker Details

Brittany L Dulmage, MD, FAAD

Brittany L Dulmage, MD, FAAD

SESSIONS

U072 What is Safe to Use for Routine Dermatologic Disease if Your Patient Has Been Diagnosed with Cancer?
Mar 29, 2026 • 4:30 PM - 5:30 PM • Mile High 1A
F092 The Morbilliform Eruption: Differentiation and Treatment of Viral, Low-Risk Drug, Severe Cutaneous Adverse Reactions, and GVHD
Mar 30, 2026 • 1:00 PM - 3:00 PM • Mile High 1A

DISCLOSURES

Azitra, Inc – Investigator(Grants/Research Funding); Hoth Therapeutics – Data Safety Monitoring Board(Honoraria); Novocure – Consultant (1099 relationship)(Honoraria); Xencor – Consultant (1099 relationship)(Fees);